Standout Papers

Overriding Imatinib Resis... 2004 2026 2011 2018 2004 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
    2004 1.4k citations Neil P. Shah, Chris Tran et al. Science profile →

Immediate Impact

2 by Nobel laureates 33 from Science/Nature 98 hit
Sub-graph 1 of 16

Citing Papers

The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
2020 Hit
A view on drug resistance in cancer
2019 HitNature
26 intermediate papers

Works of Derek Norris being referenced

Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
2004 HitScience

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Derek Norris 1.0k 741 500 468 361 19 1.7k
Ping Chen 1.2k 1.1× 757 1.0× 504 1.0× 541 1.2× 142 0.4× 23 1.7k
Denise K. Walters 1.1k 1.0× 731 1.0× 515 1.0× 718 1.5× 99 0.3× 41 2.0k
Mohammad Azam 858 0.8× 667 0.9× 364 0.7× 695 1.5× 144 0.4× 35 1.6k
Francis Y. F. Lee 577 0.6× 392 0.5× 223 0.4× 585 1.3× 341 0.9× 16 1.8k
Lily L. Remsing Rix 463 0.5× 359 0.5× 224 0.4× 902 1.9× 259 0.7× 28 1.8k
Susan E. Kiefer 405 0.4× 283 0.4× 196 0.4× 619 1.3× 237 0.7× 21 1.4k
Ji Yuan Wu 907 0.9× 803 1.1× 496 1.0× 708 1.5× 68 0.2× 44 2.1k
T G Lugo 1.0k 1.0× 721 1.0× 374 0.7× 1.0k 2.2× 71 0.2× 25 2.1k
G. Vignir Helgason 970 0.9× 461 0.6× 161 0.3× 1.1k 2.3× 64 0.2× 39 1.9k
Nandini Kishore 260 0.3× 202 0.3× 500 1.0× 450 1.0× 156 0.4× 20 1.9k

All Works

Loading papers...

Rankless by CCL
2026